FDA Warning Letter — Xinxiang Pharmaceutical Co., Ltd.
The FDA took a Warning Letter action against Xinxiang Pharmaceutical Co., Ltd. on August 19, 2016 (Xinxiang, China). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Xinxiang Pharmaceutical Co., Ltd.
- Date
- August 19, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Center
- CDER
- Location
- Xinxiang (China)